Athersys
ATHX
#10565
Rank
A$1.19 M
Marketcap
A$0.01939
Share price
-33.50%
Change (1 day)
-99.03%
Change (1 year)

Earnings for Athersys (ATHX)

Earnings in 2023 (TTM): -A$62.62 Million

According to Athersys's latest financial reports the company's current earnings are A$0.08 Million. In 2022 the company made an earning of -A$0.12 Billion, an increase over its 2021 earnings that were of -A$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Athersys from 2007 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$62.62 Million-43.38%
2022 -A$0.12 Billion-11.54%
2021 -A$0.13 Billion11.14%
2020 -A$0.12 Billion72.2%
2019 -A$65.33 Million77.29%
2018 -A$36.85 Million-22.91%
2017 -A$47.8 Million111.89%
2016 -A$22.56 Million-8.52%
2015 -A$24.66 Million-40.81%
2014 -A$41.67 Million18.62%
2013 -A$35.13 Million
2011 -A$19.79 Million19.71%
2010 -A$16.53 Million-26.28%
2009 -A$22.43 Million-18.21%
2008 -A$27.42 Million-8.28%
2007 -A$29.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.52 B-77,672.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.01 B-28,479.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$11.83 B-19,840.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$13.06 B-21,890.77%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$33.15 B-55,389.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$11.53 B-19,335.19%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
A$0.23 B-496.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-A$4.52 Billion 7,430.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-A$0.91 Billion 1,401.18%๐Ÿ‡บ๐Ÿ‡ธ USA